Investment Thesis
Relay Therapeutics share price performance since IPO
(Source: TradingView)
Investors looking to place a bet on the next big biotech trend may want to take a close look at Relay Therapeutics (RLAY), a novel drug discovery startup with a strong management team, access to one of the world's most powerful supercomputers, and nearly $1 billion in funding, having completed the third-largest biotech IPO of all time in mid-July.
Relay's upsized IPO raised $400 million after the company sold 20 million shares for $20 - above the marketed range of $18-19